Barentsz, J. O., Jager, G. J., Witjes, J. A. & Ruijs, J. H. J. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur. Radiol. 6, 129–133 (1996).
Article CAS PubMed Google Scholar
Barentsz, J. O. et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology 207, 791–797 (1998).
Article CAS PubMed Google Scholar
Barentsz, J. O. et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201, 185–193 (1996).
Article CAS PubMed Google Scholar
Barentsz, J. O., Ruijs, S. H. & Strijk, S. P. The role of MR imaging in carcinoma of the urinary bladder. Am. J. Roentgenol. 160, 937–947 (1993).
Fisher, M. R., Hricak, H. & Tanagho, E. A. Urinary bladder MR imaging. Part II. Neoplasm. Radiology 157, 471–477 (1985).
Article CAS PubMed Google Scholar
Verma, S. et al. Urinary bladder cancer: role of MR imaging. RadioGraphics 32, 371–387 (2012).
Panebianco, V. et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur. Urol. 74, 294–306 (2018).
Article PubMed PubMed Central Google Scholar
Barentsz, J. O. et al. ESUR prostate MR guidelines 2012. Eur. Radiol. 22, 746–757 (2012).
Article PubMed PubMed Central Google Scholar
Weinreb, J. C. et al. PI-RADS prostate imaging — reporting and data system: 2015, version 2. Eur. Urol. 69, 16–40 (2016).
Turkbey, B. et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur. Urol. 76, 340–351 (2019).
Jazayeri, S. B. et al. Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis. Abdom. Radiol. 47, 4173–4185 (2022).
Luo, C., Huang, B., Wu, Y., Chen, J. & Chen, L. Use of vesical imaging-reporting and data system (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis. Eur. Radiol. 30, 4606–4614 (2020).
Del Giudice, F. et al. The accuracy of vesical imaging-reporting and data system (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations. World J. Urol. 40, 1617–1628 (2022).
Article PubMed PubMed Central Google Scholar
Feng, Y., Zhong, K., Chen, R. & Zhou, W. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis. Abdom. Radiol. 47, 1396–1405 (2022).
Jazayeri, S. B. et al. Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: a systematic review and diagnostic meta-analysis. Urol. Oncol. 40, 45–55 (2022).
Article CAS PubMed Google Scholar
Del Giudice, F. et al. Systematic review and meta-analysis of vesical imaging-reporting and data system (VI-RADS) inter-observer reliability: an added value for muscle invasive bladder cancer detection. Cancers 12, 2994 (2020).
Article PubMed PubMed Central Google Scholar
Woo, S. et al. Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur. Urol. Oncol. 3, 306–315 (2020).
Article PubMed PubMed Central Google Scholar
Messina, E. et al. Seeing is believing: state of the art imaging of bladder cancer. Semin. Radiat. Oncol. 33, 12–20 (2023).
Panebianco, V. et al. VI-RADS for bladder cancer: current applications and future developments. J. Magn. Reson. Imaging 55, 23–36 (2022).
Del Giudice, F. et al. Prospective assessment of vesical imaging reporting and data system (VI-RADS) and its clinical impact on the management of high-risk non–muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur. Urol. 77, 101–109 (2020).
Cao, B. et al. Preliminary exploration of the application of vesical imaging reporting and data system (VI‐RADS) in post‐treatment patients with bladder cancer: a prospective single‐center study. Magn. Reson. Imaging 55, 275–286 (2022).
Del Giudice, F. et al. Preoperative detection of VI-RADS (Vesical Imaging-Reporting and Data System) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time-to-cystectomy: time to reconsider the nee. BJU Int. 126, 610–619 (2020).
Kimura, K. et al. Novel utility of vesical imaging-reporting and data system in multimodal treatment for muscle-invasive bladder cancer. Eur. Radiol. 33, 6245–6255 (2023).
Article CAS PubMed Google Scholar
Zhang, X. et al. Muscle-invasive bladder cancer: pretreatment prediction of response to neoadjuvant chemotherapy with diffusion-weighted MR imaging. Abdom. Radiol. 47, 2148–2157 (2022).
Pecoraro, M. et al. Vesical imaging-reporting and data system (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom. Radiol. 47, 763–770 (2022).
Witjes, A. et al. EAU guidelines on muscle-invasive and metastatic bladder cancer. uroweb https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer (2023).
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).
Article PubMed PubMed Central Google Scholar
Whiting, P. F. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155, 529 (2011).
Trevelyan, E. G. & Robinson, P. N. Delphi methodology in health research: how to do it? Eur. J. Integr. Med. 7, 423–428 (2015).
Yeh, J. S., Van Hoof, T. J. & Fischer, M. A. Key features of academic detailing: development of an expert consensus using the Delphi method. Am. Health Drug. Benefits 9, 42–50 (2016).
PubMed PubMed Central Google Scholar
Wang, H. et al. Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 291, 668–674 (2019).
Kim, S. H. Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor. Abdom. Radiol. 45, 491–498 (2019).
Liu, S. et al. Evaluation of vesical imaging-reporting and data system (VI-RADS) scoring system in predicting muscle invasion of bladder cancer. Transl. Androl. Urol. 9, 445–451 (2020).
Article PubMed PubMed Central Google Scholar
Wang, Z. et al. Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer. Cancer Imaging 20, 26 (2020).
Article PubMed PubMed Central Google Scholar
Wang, X. et al. Detecting muscle invasion of bladder cancer using a proposed magnetic resonance imaging strategy. J. Magn. Reson. Imaging 54, 1212–1221 (2021).
Arita, Y. et al. Diagnostic value of the vesical imaging-reporting and data system in bladder urothelial carcinoma with variant histology. Eur. Urol. Oncol. S2588-9311, 00136–5 (2022).
Noh, T. I. et al. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS. Sci. Rep. 12, 20689 (2022).
Article CAS PubMed PubMed Central Google Scholar
Makboul, M., Farghaly, S. & Abdelkawi, I. F. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application. Br J Radiol 92, 20190401 (2019).
Article PubMed PubMed Central Google Scholar
Taguchi, S. et al. Prospective validation of vesical imaging-reporting and data system using a next-generation magnetic resonance imaging scanner-is denoising deep learning reconstruction useful? J. Urol. 205, 686–692 (2021).
Akcay, A. et al. VI-RADS score and tumor contact length in MRI: a potential method for the detection of muscle invasion in bladder cancer. Clin. Imaging 77, 25–36 (2021).
Metwally, M. I. et al. The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur. Radiol. 31, 6949–6961 (2021).
Erkoc, M. et al. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer. Int. J. Clin. Pract. 75, e14584 (2021).
Comments (0)